Plasma Catestatin in Patients with Acute Coronary Syndrome.
作者： Weixian Xu , Haiyi Yu , Hubing Wu , Siheng Li , Baoxia Chen
DOI: 10.1159/000448987
关键词: St elevation myocardial infarction 、 Medicine 、 Coronary angiography 、 Myocardial infarction 、 Heart failure 、 Case-control study 、 In patient 、 Internal medicine 、 Acute coronary syndrome 、 Cardiology
摘要: Objectives: To measure plasma catestatin levels in patients with acute coronary syndrome and investigate whether there is an association between
sci-hub.se 参考文章(23)
Lin Liu, Wenhui Ding, Renxu Li, Xiaojin Ye, Jing Zhao, Jie Jiang, Lei Meng, Jie Wang, Songyun Chu, Xiaoning Han, Fen Peng, Plasma levels and diagnostic value of catestatin in patients with heart failure Peptides. ,vol. 46, pp. 20- 25 ,(2013) , 10.1016/J.PEPTIDES.2013.05.003
Zhiqiang Pei, Dengfeng Ma, Lei Ji, Jing Zhang, Jinsheng Su, Weizhen Xue, Xiaoping Chen, Weishu Wang, Usefulness of catestatin to predict malignant arrhythmia in patients with acute myocardial infarction. Peptides. ,vol. 55, pp. 131- 135 ,(2014) , 10.1016/J.PEPTIDES.2014.02.016
Marvin Bacaner, James Brietenbucher, John LaBree, Prevention of Ventricular Fibrillation, Acute Myocardial Infarction (Myocardial Necrosis), Heart Failure, and Mortality by Bretylium American Journal of Therapeutics. ,vol. 11, pp. 366- 411 ,(2004) , 10.1097/01.MJT.0000126444.24163.81
Simona Ferraro, Ilaria Ardoino, Patrizia Boracchi, Matteo Santagostino, Laura Ciardi, Giuseppina Antonini, Federica Braga, Elia Biganzoli, Mauro Panteghini, Angelo S. Bongo, Inside ST-elevation myocardial infarction by monitoring concentrations of cardiovascular risk biomarkers in blood Clinica Chimica Acta. ,vol. 413, pp. 888- 893 ,(2012) , 10.1016/J.CCA.2012.01.034
S K Mahata, D T O'Connor, M Mahata, S H Yoo, L Taupenot, H Wu, B M Gill, R J Parmer, Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. Journal of Clinical Investigation. ,vol. 100, pp. 1623- 1633 ,(1997) , 10.1172/JCI119686
Lin Liu, Wenhui Ding, Feng Zhao, Libin Shi, Yongzheng Pang, Chaoshu Tang, Plasma levels and potential roles of catestatin in patients with coronary heart disease. Scandinavian Cardiovascular Journal. ,vol. 47, pp. 217- 224 ,(2013) , 10.3109/14017431.2013.794951
Dan Zhu, Hong Xie, Xinyu Wang, Ying Liang, Haiyi Yu, Wei Gao, Correlation of Plasma Catestatin Level and the Prognosis of Patients with Acute Myocardial Infarction PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0122993
Daniel T. O'Connor, Mala T. Kailasam, Brian P. Kennedy, Michael G. Ziegler, Noboru Yanaihara, Robert J. Parmer, Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. Journal of Hypertension. ,vol. 20, pp. 1335- 1345 ,(2002) , 10.1097/00004872-200207000-00020
Xinyu Wang, Shunlin Xu, Ying Liang, Dan Zhu, Lin Mi, Guisong Wang, Wei Gao, Dramatic changes in catestatin are associated with hemodynamics in acute myocardial infarction. Biomarkers. ,vol. 16, pp. 372- 377 ,(2011) , 10.3109/1354750X.2011.578260
A. M. Jansson, H. Rosjo, T. Omland, T. Karlsson, M. Hartford, A. Flyvbjerg, K. Caidahl, Prognostic value of circulating chromogranin A levels in acute coronary syndromes. European Heart Journal. ,vol. 30, pp. 25- 32 ,(2008) , 10.1093/EURHEARTJ/EHN513